Prasugrel better than clopidogrel in reducing intra-stent tissue in ACS patients | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis | ACS Biomaterials Science & Engineering
Duration of Dual Anti-Platelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents | SCAI
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison | Journal of the American College of Cardiology
Three-Month DAPT Non-Inferior for ACS Patients Treated With Combo Dual Therapy Stent | DAIC
Antiplatelet therapy after percutaneous coronary intervention - EuroIntervention
Polymer-free drug-eluting stents — a safe and effective option for ACS | Nature Reviews Cardiology
Titanium-Nitride-Oxide–Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial - ScienceDirect
Causes of Early Stent Thrombosis in Patients Presenting With Acute Coronary Syndrome: An Ex Vivo Human Autopsy Study - ScienceDirect
Risk of Elective Major Noncardiac Surgery After Coronary Stent Insertion | tctmd.com
Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis | The BMJ
5 Pearls on Dual Antiplatelet Therapy (DAPT) | Core IM Podcast
A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis | ACS Biomaterials Science & Engineering
JCM | Free Full-Text | Clinical Outcomes of Different Calcified Culprit Plaques in Patients with Acute Coronary Syndrome
Use of drug-eluting versus bare-metal stents after an acute coronary syndrome in Portugal: The EURHOBOP study | Revista Portuguesa de Cardiologia (English edition)
Flow chart. ACS, acute coronary syndrome; LST, late stent thrombosis;... | Download Scientific Diagram
Antiplatelet therapy after percutaneous coronary intervention - EuroIntervention
Figure 50, Relative Risk of Definite or Probable Stent Thrombosis by Acute Coronary Syndrome Status - Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration -
SOLACI | Latin American Society of Interventional Cardiology
ACS Mukti-link RX Duet coronary stent by Guidant (1998)
DAY 3 - Acute Coronary Syndromes — The Intern at Work
Ticagrelor Versus Clopidogrel in Patients with Late or Very Late Stent Thrombosis | SpringerLink
Acute Coronary Syndrome – Explained By A Cardiologist • MyHeart
One-year clinical outcomes of patients with versus without acute coronary syndrome with 3-month duration of dual antiplatelet therapy after everolimus-eluting stent implantation | PLOS ONE
Bioresorbable Electronic Stent Integrated with Therapeutic Nanoparticles for Endovascular Diseases | ACS Nano
